Therapeutic targets for rheumatoid arthritis.
Keystone
Edward C
EC
Haraoui
Boulos
B
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D001688:Biological Products / Q000627:therapeutic use*; D006801:Humans; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D001688:Biological Products